Open AccessTherapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study
Author(s) -
Yonghua Li,
Duan Fu-jian,
Haowen Xiao,
Xue-Ru Wu,
Shunqing Wang,
Duorong Xu,
Qifa Liu,
Fan Zhang,
Danian Nie,
Yongrong Lai,
Bingyi Wu,
Dongjun Lin,
Xin Du,
Jianyu Weng,
Zujun Jiang,
Yan Pang,
Ling Ouyang,
Zenghui Liu,
Leqin Zhang,
Na Han,
Lixuan Chen,
X. B. Yang
Publication year - 2018
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002200
Subject(s) - medicine , hematopoietic stem cell transplantation , aplastic anemia , incidence (geometry) , transplantation , surgery , anemia , cumulative incidence , gastroenterology , bone marrow , physics , optics
Haploidentical donor (HID) allogeneic hematopoietic stem cell transplantation (HSCT) is an alternative curative treatment for patients with severe aplastic anemia (SAA) who do not have suitable matched related donors (MRD). The aim of this study was to compare the therapeutic outcomes of HID-HSCT with those of MRD-HSCT for SAA.